GSK Heart Drug Disappoints

Written By The USA Links on Tuesday, 12 November 2013 | 07:57


WSJ.com: US Business

GSK Heart Drug Disappoints

[unable to retrieve full-text content]One of GlaxoSmithKline's major drug investments has failed to lower the risk of heart attack or stroke among chronic-heart-disease patients, the company said after it concluded the first of two late-stage trials of the drug.



0 comments:

Post a Comment